SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-008519
Filing Date
2024-01-31
Accepted
2024-01-31 17:17:54
Documents
16
Period of Report
2024-01-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192507-8k425_10xcap3.htm   iXBRL 8-K 37678
2 PRESS RELEASE, DATED JANUARY 31, 2024 ea192507ex99-1_10xcap3.htm EX-99.1 5162
  Complete submission text file 0001213900-24-008519.txt   275107

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vcxb-20240129.xsd EX-101.SCH 4221
4 XBRL DEFINITION FILE vcxb-20240129_def.xml EX-101.DEF 27375
5 XBRL LABEL FILE vcxb-20240129_lab.xml EX-101.LAB 38052
6 XBRL PRESENTATION FILE vcxb-20240129_pre.xml EX-101.PRE 25995
17 EXTRACTED XBRL INSTANCE DOCUMENT ea192507-8k425_10xcap3_htm.xml XML 7567
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 24583954
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)